Michael  Lefenfeld net worth and biography

Michael Lefenfeld Biography and Net Worth

Director of Immunome
Michael Lefenfeld is the president and chief executive officer of Cyanco, the leading global supplier of reagents and technologies which enable commercial mining of precious metals – Gold and Silver.  He is also the co-founder and former chief executive officer of SiGNa Chemistry, a global manufacturer of highly-active, environmentally friendly chemicals. SiGNa’s products are used to improve production processes in the energy recovery, petrochemical refining and chemical manufacturing industries. His work has led to safer industrial environments, better medical technologies and more effective, affordable energy solutions. Prior to SiGNa, Lefenfeld developed and commercialized several new technologies, launching and selling three companies by age 30. Lefenfeld holds more than 50 patents in medical devices, controlled release, electronics, chemical reactivity and information technology. After earning a bachelor’s degree in chemical engineering at WashU in 2002, Lefenfeld, a resident of New York City, earned a master’s in chemistry at Columbia University and an executive education certificate at Stanford University’s Graduate School of Business.

What is Michael Lefenfeld's net worth?

The estimated net worth of Michael Lefenfeld is at least $802,752.68 as of May 24th, 2021. Mr. Lefenfeld owns 46,726 shares of Immunome stock worth more than $802,753 as of April 19th. This net worth approximation does not reflect any other investments that Mr. Lefenfeld may own. Learn More about Michael Lefenfeld's net worth.

How do I contact Michael Lefenfeld?

The corporate mailing address for Mr. Lefenfeld and other Immunome executives is , , . Immunome can also be reached via phone at 610-321-3700 and via email at [email protected]. Learn More on Michael Lefenfeld's contact information.

Has Michael Lefenfeld been buying or selling shares of Immunome?

Michael Lefenfeld has not been actively trading shares of Immunome within the last three months. Most recently, on Wednesday, May 26th, Michael Lefenfeld bought 1,335 shares of Immunome stock. The stock was acquired at an average cost of $19.03 per share, with a total value of $25,405.05. Following the completion of the transaction, the director now directly owns 22,822 shares of the company's stock, valued at $434,302.66. Learn More on Michael Lefenfeld's trading history.

Who are Immunome's active insiders?

Immunome's insider roster includes Michael Lefenfeld (Director), Michael Rapp (Director), and Purnanand Sarma (CEO). Learn More on Immunome's active insiders.

Are insiders buying or selling shares of Immunome?

In the last twelve months, Immunome insiders bought shares 2 times. They purchased a total of 211,504 shares worth more than $1,249,988.64. The most recent insider tranaction occured on October, 2nd when CEO Clay B Siegall bought 169,204 shares worth more than $999,995.64. Insiders at Immunome own 20.0% of the company. Learn More about insider trades at Immunome.

Information on this page was last updated on 10/2/2023.

Michael Lefenfeld Insider Trading History at Immunome

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/26/2021Buy1,335$19.03$25,405.0522,822View SEC Filing Icon  
5/24/2021Buy600$17.80$10,680.0046,726View SEC Filing Icon  
See Full Table

Michael Lefenfeld Buying and Selling Activity at Immunome

This chart shows Michael Lefenfeld's buying and selling at Immunome by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Immunome Company Overview

Immunome logo
Immunome, Inc. operates as a biotechnology company that develops targeted cancer therapies. Its portfolio includes immunotherapies, targeted effectors, radioligand therapies, and antibody drug conjugates (ADCs). The company also offers rapid screening of novel antibodies and targets through memory B cell hybridoma technology. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.
Read More

Today's Range

Now: $17.18
Low: $17.15
High: $17.97

50 Day Range

MA: $23.03
Low: $17.18
High: $27.34

2 Week Range

Now: $17.18
Low: $4.44
High: $30.96

Volume

852,654 shs

Average Volume

699,043 shs

Market Capitalization

$1.03 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.66